Literature DB >> 16785856

Polymorphism of beta-adrenergic receptors and susceptibility to open-angle glaucoma.

Yoko Inagaki1, Yukihiko Mashima, Nobuo Fuse, Tomoyo Funayama, Yuichiro Ohtake, Noriko Yasuda, Akira Murakami, Yoshihiro Hotta, Takeo Fukuchi, Kazuo Tsubota.   

Abstract

PURPOSE: The human trabecular meshwork and ciliary body, which express beta-adrenergic receptors (ADRB1 and ADRB2), control aqueous humor dynamics. We investigated associations of ADRB polymorphisms with open-angle glaucoma (OAG), because ADRB gene polymorphisms alter receptor function.
METHODS: We studied 240 Japanese controls and 505 Japanese OAG patients including 211 with primary open-angle glaucoma (POAG), and 294 with normal-tension glaucoma (NTG). Associations of four polymorphisms (Ser49Gly and Arg389Gly in the ADRB1 gene; Arg16Gly and Gln27Glu in the ADRB2 gene) were compared between patients and controls. Age, intraocular pressure (IOP), and visual field defects at diagnosis were examined for associations with polymorphisms.
RESULTS: The Arg389Gly polymorphism in the ADRB1 gene showed significantly different allele and genotype frequencies in patients with NTG than in controls (p = 0.004 and 0.006, respectively). Other polymorphisms did not show a significant frequency difference. In POAG patients, carriers of Gly16 in the ADRB2 gene were significantly younger at diagnosis than noncarriers (p<0.001). The IOP at diagnosis was significantly higher in OAG patients carrying 27Glu in the ADRB2 gene than in patients without this allele (p<0.001). Clinical characteristics of OAG patients did not differ significantly in relation to other polymorphisms.
CONCLUSIONS: Certain polymorphisms of the ADRB1 and ADRB2 genes influence the pathophysiology of OAG in Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785856

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  11 in total

1.  Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma.

Authors:  J H Kang; S J Loomis; B L Yaspan; J C Bailey; R N Weinreb; R K Lee; P R Lichter; D L Budenz; Y Liu; T Realini; D Gaasterland; T Gaasterland; D S Friedman; C A McCarty; S E Moroi; L Olson; J S Schuman; K Singh; D Vollrath; G Wollstein; D J Zack; M Brilliant; A J Sit; W G Christen; J Fingert; J P Forman; E S Buys; P Kraft; K Zhang; R R Allingham; M A Pericak-Vance; J E Richards; M A Hauser; J L Haines; J L Wiggs; L R Pasquale
Journal:  Eye (Lond)       Date:  2014-03-07       Impact factor: 3.775

Review 2.  Glaucoma: genes, phenotypes, and new directions for therapy.

Authors:  Bao Jian Fan; Janey L Wiggs
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

3.  Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients.

Authors:  Li-chen Gao; Di Wang; Fang-qun Liu; Zheng-yu Huang; Hong-guang Huang; Gui-hua Wang; Xi Chen; Qun-zhi Shi; Li Hong; Li-ping Wu; Jie Tang
Journal:  Eur J Clin Pharmacol       Date:  2014-10-23       Impact factor: 2.953

4.  Investigation of the association between the GLC3A locus and normal tension glaucoma in Japanese patients by microsatellite analysis.

Authors:  M Kamio; A Meguro; M Ota; N Nomura; K Kashiwagi; F Mabuchi; H Iijima; K Kawase; T Yamamoto; M Nakamura; A Negi; T Sagara; T Nishida; M Inatani; H Tanihara; M Aihara; M Araie; T Fukuchi; H Abe; T Higashide; K Sugiyama; T Kanamoto; Y Kiuchi; A Iwase; S Ohno; H Inoko; N Mizuki
Journal:  Clin Ophthalmol       Date:  2009-06-02

5.  VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humans.

Authors:  Keiko Fujikawa; Takeshi Iwata; Kaoru Inoue; Masakazu Akahori; Hanako Kadotani; Masahiro Fukaya; Masahiko Watanabe; Qing Chang; Edward M Barnett; Wojciech Swat
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

Review 6.  Molecular complexity of primary open angle glaucoma: current concepts.

Authors:  Kunal Ray; Suddhasil Mookherjee
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

7.  Pharmacogenetics of ophthalmic topical beta-blockers.

Authors:  Duska J Sidjanin; Catherine A McCarty; Richard Patchett; Edward Smith; Russell A Wilke
Journal:  Per Med       Date:  2008       Impact factor: 2.512

8.  Progress toward personalized medicine for glaucoma.

Authors:  Sayoko E Moroi; Duna A Raoof; David M Reed; Sebastian Zöllner; Zhaohui Qin; Julia E Richards
Journal:  Expert Rev Ophthalmol       Date:  2009-04

9.  Investigation of the association between interleukin-1beta polymorphism and normal tension glaucoma.

Authors:  Chun Yuan Wang; Ying-Cheng Shen; Chien-Hui Su; Fai-Yun Lo; Shi-Huang Lee; Hin-Yeung Tsai; Seng-Sheen Fan
Journal:  Mol Vis       Date:  2007-05-14       Impact factor: 2.367

Review 10.  Muscarinic Acetylcholine Receptors in the Retina-Therapeutic Implications.

Authors:  Yue Ruan; Andreas Patzak; Norbert Pfeiffer; Adrian Gericke
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.